Biopharmaceutics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
Aims and scope
The Section ‘’Biopharmaceutics” of the open-access journal Pharmaceutics will publish novel, original, peer-reviewed research manuscripts, short communications, and invited topical reviews in all areas of Biopharmaceutics. “Biopharmaceutics” focuses on fundamental and applied research, including the relationship between a drug’s pharmacokinetic, physical, and chemical properties, the dosage form or delivery system into which it is included, the route of administration, and the resulting therapeutic and toxic response. In particular (but not exclusively), this Section invites contributions that report on these topics:
Concepts in ADME and drug exposure
- Absorption: mechanisms and routes of absorption, absorption enhancement;
- Drug distribution: mechanisms, kinetics and approaches to drug targeting;
- Drug elimination: metabolism and excretion, processes and kinetics, metabolites and prodrugs;
- Impact of physiological and pathological factors on drug absorption, distribution, metabolism and excretion (ADME);
- Variability in ADME and special populations;
- Bioavailability and bioequivalence;
- Pharmacokinetics and the PK–PD relationship;
- ADME of biologicals.
Dosage forms
- Drug release: mechanisms and factors that impact the process;
- Strategies and formulations for controlled drug transport across biological barriers;
- Targeted drug delivery at organic, tissue, molecular, cellular levels;
- Novel drug delivery technologies;
- Personalized dosage forms;
- Pharmaceutical preformulation and formulation developments;
- Optimizing the safety and efficacy of therapies through medicines design;
- Modulating ADME through medicine design.
Integration of drug dosage and form biology concepts
- In vitro/in vivo correlations;
- Preclinical and clinical evaluation of formulation technologies and drug delivery systems;
- Biological membranes: modelling and simulation, drug transport;
- Understanding of biological barriers to drug release in health and disease.
Authors will enjoy a high-quality review process, rapid publication, and high visibility through access to a broad readership.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Drug Delivery for Natural Extract Applications (Deadline: 20 August 2026)
- Biomaterials: Pharmaceutical Applications (Deadline: 31 August 2026)
- Bioactive Phytochemicals from Medicinal Plants: Formulation and Therapeutic Potential (Deadline: 31 August 2026)
- Understanding Drug Disposition: The Interplay of Absorption, Distribution, and Excretion Processes, and Transport Mechanisms (Deadline: 30 September 2026)
- Advances in Solid and Semi-Solid Dosage Form Design for Enhanced Biopharmaceutical Performance (Deadline: 31 October 2026)
- Bioequivalence Evaluation of Topical Drugs (Deadline: 31 October 2026)
- From Nature to Pharmacy: Advances in Bio-Based Pharmaceutical Formulations (Deadline: 31 October 2026)
- New Approach Methodologies in Biopharmaceutics: Towards a More Humane Drug Development (Deadline: 30 November 2026)
- Design of Dosage Forms to Enhance Biopharmaceutical Properties (Deadline: 20 December 2026)
- Studies of Protein–Ligand Interactions in the Evaluation of the Biological Activity of Compounds (Deadline: 31 December 2026)
- Natural Products in Pharmaceutics: From Bioactive Compounds to Nanomedicine (Deadline: 31 December 2026)
- Novel Strategies for Enhancing Oral Bioavailability (Deadline: 31 December 2026)
- Bioavailability and Bioequivalence Assessment of Topical Drug Products Intended for Local Action (Deadline: 31 December 2026)
- Delivery System for Biomacromolecule Drugs: Design and Application, 2nd Edition (Deadline: 20 January 2027)
- Biomarker-Guided Drug Delivery Systems and Oral Bioavailability Enhancement (Deadline: 31 January 2027)
- Advanced Biomaterial-Based Systems for Drug Delivery and Regenerative Medicine (Deadline: 28 February 2027)
- Drug Product Performance: Bioavailability, Relative Bioavailability and Bioequivalence, 3rd Edition (Deadline: 10 March 2027)
- New Therapeutic Approaches for the Application of Natural Products in Skin Diseases (Deadline: 25 March 2027)
- Advanced Characterization and Bioequivalence Strategies for Complex Long-Acting Injectable Systems (Deadline: 31 March 2027)
- New Vehicle Formulations for Skin Diseases (Deadline: 31 March 2027)